These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6272625)

  • 1. Eaton-Lambert myasthenic syndrome: long-term treatment of three patients with prednisone.
    Streib EW; Rothner AD
    Ann Neurol; 1981 Nov; 10(5):448-53. PubMed ID: 6272625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A diagnostic and management dilemma: combined paraneoplastic myasthenia gravis and Lambert-Eaton myasthenic syndrome presenting as acute respiratory failure.
    Roohi F; Smith PR; Bergman M; Baig MA; Sclar G
    Neurologist; 2006 Nov; 12(6):322-6. PubMed ID: 17122730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of myasthenia gravis and Lambert-Eaton syndrome.
    Maselli RA
    Neurol Clin; 1994 May; 12(2):285-303. PubMed ID: 8041343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-neoplastic Lambert-Eaton syndrome. A frequently missed diagnosis?].
    Sieb JP; Dengler R; Jerusalem F
    Nervenarzt; 1992 Apr; 63(4):234-9. PubMed ID: 1317512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmapheresis and immunosuppressive drug therapy in the Eaton-Lambert syndrome.
    Dau PC; Denys EH
    Ann Neurol; 1982 Jun; 11(6):570-5. PubMed ID: 7114807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine in the treatment of myasthenia gravis.
    Witte AS; Cornblath DR; Parry GJ; Lisak RP; Schatz NJ
    Ann Neurol; 1984 Jun; 15(6):602-5. PubMed ID: 6742794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of systemic lupus erythematosus and Lambert-Eaton myasthenic syndrome.
    Deodhar A; Norden J; So Y; Bennett R
    J Rheumatol; 1996 Jul; 23(7):1292-4. PubMed ID: 8823710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit from alternate-day prednisone in myasthenia gravis.
    Warmolts JR; Engel WK
    N Engl J Med; 1972 Jan; 286(1):17-20. PubMed ID: 4331158
    [No Abstract]   [Full Text] [Related]  

  • 11. Decrement pattern in Lambert-Eaton myasthenic syndrome is different from myasthenia gravis.
    Baslo MB; Deymeer F; Serdaroglu P; Parman Y; Ozdemir C; Cuttini M
    Neuromuscul Disord; 2006 Jul; 16(7):454-8. PubMed ID: 16806929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Eaton-Lambert syndrome. Long-term treatment with corticoids].
    Illa I; Pradas J; Vázquez J; Codina M
    Med Clin (Barc); 1986 May; 86(18):782. PubMed ID: 3736183
    [No Abstract]   [Full Text] [Related]  

  • 13. Myasthenia gravis and myasthenic syndrome: simulation of twitch strength with or without therapy.
    Nigrovic V; Amann A; Bhatt S
    Muscle Nerve; 2005 Dec; 32(6):745-50. PubMed ID: 16094654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical predictors of steroid-induced exacerbation in myasthenia gravis.
    Bae JS; Go SM; Kim BJ
    J Clin Neurosci; 2006 Dec; 13(10):1006-10. PubMed ID: 17074487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic approaches to Lambert-Eaton myasthenic syndrome in the intra-individual comparison.
    Jost WH; Mielke U; Schimrigk K
    Wien Klin Wochenschr; 1991; 103(20):629-32. PubMed ID: 1763511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eaton-Lambert myasthenic syndrome: serial electromyographic studies during prednisone treatment. Case study.
    Streib EW
    Electromyogr Clin Neurophysiol; 1981; 21(2-3):107-20. PubMed ID: 7261996
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients.
    Pascuzzi RM; Coslett HB; Johns TR
    Ann Neurol; 1984 Mar; 15(3):291-8. PubMed ID: 6721451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anconeus muscle: a human muscle preparation suitable for in-vitro microelectrode studies.
    Maselli RA; Mass DP; Distad BJ; Richman DP
    Muscle Nerve; 1991 Dec; 14(12):1189-92. PubMed ID: 1662771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atypical paraneoplastic myasthenic syndrome: Lambert-Eaton syndrome or myasthenia?].
    Ferroir JP; Milleron B; Ropert A; Billy C; Nahum L; Tcherakian S; Carette MF
    Rev Pneumol Clin; 1999 Jun; 55(3):168-70. PubMed ID: 10486838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.